Cargando…
DSP30和IL-2在慢性淋巴细胞白血病常规染色体检测中的应用
OBJECTIVE: To study the value of unmethylated cytosine guanine dinucleotide oligodeoxynucleotide (DSP30) and IL-2 in the conventional cytogenetic (CA) detection of the chromosomal aberrations in chronic lymphocytic leukemia (CLL). METHODS: Bone marrow or peripheral blood cells of CLL patients were c...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357944/ https://www.ncbi.nlm.nih.gov/pubmed/32135632 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.02.011 |
_version_ | 1783558765982777344 |
---|---|
collection | PubMed |
description | OBJECTIVE: To study the value of unmethylated cytosine guanine dinucleotide oligodeoxynucleotide (DSP30) and IL-2 in the conventional cytogenetic (CA) detection of the chromosomal aberrations in chronic lymphocytic leukemia (CLL). METHODS: Bone marrow or peripheral blood cells of CLL patients were cultured with DSP30 plus IL-2 for 72 h, following which R-banding analysis was conducted. Fluorescence in situ hybridization (FISH) was performed in 85 patients. CA results were compared with data obtained by FISH. RESULTS: Among 89 CLL patients, the success rate of chromosome analysis was 94.38% (84/89). Clonal aberrations were detected in 51 patients (51/84, 60.71%). Of them, 27 (27/51, 52.94%) were complex karyotype. Among 85 CLL patients tested by FISH, chromosomal abnormalities were detected in 74 (74/85, 87.06%) patients, of which 2 (2/74) patients were complex karyotypes, accounting for 2.70%. Of the 85 CLL patients examined by FISH, 50 had abnormal karyotype analysis, 30 had normal karyotype, 5 failed to have chromosome analysis. Among them, 25 cases showed clonal aberrations by FISH assay but normal by CA, and 4 cases were normal by FISH but displayed aberrations in chromosome analysis, and totally 78 (91.76%) cases with abnormality detected by the combination of the two methods. The frequency of 13q− abnormality detected by FISH was significantly higher than that by CA analysis (69.41%vs 16.67%, P<0.001), while the frequency of 11q−,+12 and 17p− detected by two methods showed no significant difference (P>0.05). The detection rate of complex abnormalities in conventional karyotype analysis was higher than that in FISH (50.98%vs 2.70%). In addition, 11 low-risk and 9 intermediate-risk patients according to FISH results showed complex karyotype by cytogenetics, and were classified into high-risk cytogenetic subgroup. CONCLUSION: DSP30 and IL-2 are effective in improving the detection rate of CA in CLL patients (60.71%) and CA is more effective to detect complex karyotype. However, FISH had a higher overall abnormality detection rate (87.06%) than CA, especially for 13q−. The combination of CA and FISH not only enhanced the detection rate of clonal aberrations to 91.76%, but also provided more precise prognosis stratification for CLL patients, thus to provide more information for clinical implication. |
format | Online Article Text |
id | pubmed-7357944 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Editorial office of Chinese Journal of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-73579442020-07-16 DSP30和IL-2在慢性淋巴细胞白血病常规染色体检测中的应用 Zhonghua Xue Ye Xue Za Zhi 论著 OBJECTIVE: To study the value of unmethylated cytosine guanine dinucleotide oligodeoxynucleotide (DSP30) and IL-2 in the conventional cytogenetic (CA) detection of the chromosomal aberrations in chronic lymphocytic leukemia (CLL). METHODS: Bone marrow or peripheral blood cells of CLL patients were cultured with DSP30 plus IL-2 for 72 h, following which R-banding analysis was conducted. Fluorescence in situ hybridization (FISH) was performed in 85 patients. CA results were compared with data obtained by FISH. RESULTS: Among 89 CLL patients, the success rate of chromosome analysis was 94.38% (84/89). Clonal aberrations were detected in 51 patients (51/84, 60.71%). Of them, 27 (27/51, 52.94%) were complex karyotype. Among 85 CLL patients tested by FISH, chromosomal abnormalities were detected in 74 (74/85, 87.06%) patients, of which 2 (2/74) patients were complex karyotypes, accounting for 2.70%. Of the 85 CLL patients examined by FISH, 50 had abnormal karyotype analysis, 30 had normal karyotype, 5 failed to have chromosome analysis. Among them, 25 cases showed clonal aberrations by FISH assay but normal by CA, and 4 cases were normal by FISH but displayed aberrations in chromosome analysis, and totally 78 (91.76%) cases with abnormality detected by the combination of the two methods. The frequency of 13q− abnormality detected by FISH was significantly higher than that by CA analysis (69.41%vs 16.67%, P<0.001), while the frequency of 11q−,+12 and 17p− detected by two methods showed no significant difference (P>0.05). The detection rate of complex abnormalities in conventional karyotype analysis was higher than that in FISH (50.98%vs 2.70%). In addition, 11 low-risk and 9 intermediate-risk patients according to FISH results showed complex karyotype by cytogenetics, and were classified into high-risk cytogenetic subgroup. CONCLUSION: DSP30 and IL-2 are effective in improving the detection rate of CA in CLL patients (60.71%) and CA is more effective to detect complex karyotype. However, FISH had a higher overall abnormality detection rate (87.06%) than CA, especially for 13q−. The combination of CA and FISH not only enhanced the detection rate of clonal aberrations to 91.76%, but also provided more precise prognosis stratification for CLL patients, thus to provide more information for clinical implication. Editorial office of Chinese Journal of Hematology 2020-02 /pmc/articles/PMC7357944/ /pubmed/32135632 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.02.011 Text en 2020年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal. |
spellingShingle | 论著 DSP30和IL-2在慢性淋巴细胞白血病常规染色体检测中的应用 |
title | DSP30和IL-2在慢性淋巴细胞白血病常规染色体检测中的应用 |
title_full | DSP30和IL-2在慢性淋巴细胞白血病常规染色体检测中的应用 |
title_fullStr | DSP30和IL-2在慢性淋巴细胞白血病常规染色体检测中的应用 |
title_full_unstemmed | DSP30和IL-2在慢性淋巴细胞白血病常规染色体检测中的应用 |
title_short | DSP30和IL-2在慢性淋巴细胞白血病常规染色体检测中的应用 |
title_sort | dsp30和il-2在慢性淋巴细胞白血病常规染色体检测中的应用 |
topic | 论著 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357944/ https://www.ncbi.nlm.nih.gov/pubmed/32135632 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.02.011 |
work_keys_str_mv | AT dsp30héil2zàimànxìnglínbāxìbāobáixuèbìngchángguīrǎnsètǐjiǎncèzhōngdeyīngyòng AT dsp30héil2zàimànxìnglínbāxìbāobáixuèbìngchángguīrǎnsètǐjiǎncèzhōngdeyīngyòng AT dsp30héil2zàimànxìnglínbāxìbāobáixuèbìngchángguīrǎnsètǐjiǎncèzhōngdeyīngyòng AT dsp30héil2zàimànxìnglínbāxìbāobáixuèbìngchángguīrǎnsètǐjiǎncèzhōngdeyīngyòng AT dsp30héil2zàimànxìnglínbāxìbāobáixuèbìngchángguīrǎnsètǐjiǎncèzhōngdeyīngyòng AT dsp30héil2zàimànxìnglínbāxìbāobáixuèbìngchángguīrǎnsètǐjiǎncèzhōngdeyīngyòng AT dsp30héil2zàimànxìnglínbāxìbāobáixuèbìngchángguīrǎnsètǐjiǎncèzhōngdeyīngyòng AT dsp30héil2zàimànxìnglínbāxìbāobáixuèbìngchángguīrǎnsètǐjiǎncèzhōngdeyīngyòng AT dsp30héil2zàimànxìnglínbāxìbāobáixuèbìngchángguīrǎnsètǐjiǎncèzhōngdeyīngyòng AT dsp30héil2zàimànxìnglínbāxìbāobáixuèbìngchángguīrǎnsètǐjiǎncèzhōngdeyīngyòng AT dsp30héil2zàimànxìnglínbāxìbāobáixuèbìngchángguīrǎnsètǐjiǎncèzhōngdeyīngyòng AT dsp30héil2zàimànxìnglínbāxìbāobáixuèbìngchángguīrǎnsètǐjiǎncèzhōngdeyīngyòng |